| Präparat | Galenische Form | Stärke | Packungsgrösse | PP | SB | Zulassungsinh. | | Betäubungsmittel | | | |
|---|
|
| November 2011 - 106 Präparate |
|
| Docetaxel Hospira 20 mg/2 ml | Infusionskonzentrat | 20mg / 2ml | Durchstechflasche(n) | 141.80 | 10% | Hospira Schweiz GmbH | | | | | |
| Docetaxel Hospira 80 mg/8 ml | Infusionskonzentrat | 80mg / 8ml | Durchstechflasche(n) | 518.00 | 10% | Hospira Schweiz GmbH | | | | | |
| Letrozol Sandoz | Filmtabletten | 2.5 mg | 30 Tablette(n) | 96.00 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
| Letrozol Sandoz | Filmtabletten | 2.5 mg | 100 Tablette(n) | 280.40 | 10% | Sandoz Pharmaceuticals AG | | | | FI | PI |
| Pioglitazon Actavis 15 mg | Tabletten | 15 mg | 28 Tablette(n) | 41.60 | 10% | Actavis Switzerland AG | L | | | FI | PI |
| Pioglitazon Actavis 15 mg | Tabletten | 15 mg | 98 Tablette(n) | 104.45 | 10% | Actavis Switzerland AG | L | | | FI | PI |
| Pioglitazon Actavis 30 mg | Tabletten | 30 mg | 28 Tablette(n) | 50.60 | 10% | Actavis Switzerland AG | L | | | FI | PI |
| Pioglitazon Actavis 30 mg | Tabletten | 30 mg | 98 Tablette(n) | 135.50 | 10% | Actavis Switzerland AG | L | | | FI | PI |
| Pioglitazon Actavis 45 mg | Tabletten | 45 mg | 28 Tablette(n) | 57.45 | 10% | Actavis Switzerland AG | L | | | FI | PI |
| Pioglitazon Actavis 45 mg | Tabletten | 45 mg | 98 Tablette(n) | 159.20 | 10% | Actavis Switzerland AG | L | | | FI | PI |
| Quetiapin Actavis 100 mg | Filmtabletten | 100 mg | 60 Tablette(n) | 61.60 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 100 mg | Filmtabletten | 100 mg | 60 Tablette(n) | 61.60 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 100 mg | Filmtabletten | 100 mg | 100 Tablette(n) | 90.55 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 150 mg | Filmtabletten | 150 mg | 60 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 150 mg | Filmtabletten | 150 mg | 60 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 200 mg | Filmtabletten | 200 mg | 60 Tablette(n) | 109.30 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 200 mg | Filmtabletten | 200 mg | 60 Tablette(n) | 109.30 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 200 mg | Filmtabletten | 200 mg | 100 Tablette(n) | 168.95 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 25 mg | Filmtabletten | 25 mg | 60 Tablette(n) | 35.20 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 25 mg | Filmtabletten | 25 mg | 60 Tablette(n) | 35.20 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 25 mg | Filmtabletten | 25 mg | 100 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 300 mg | Filmtabletten | 300 mg | 60 Tablette(n) | 147.70 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 300 mg | Filmtabletten | 300 mg | 60 Tablette(n) | 147.70 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Quetiapin Actavis 300 mg | Filmtabletten | 300 mg | 100 Tablette(n) | 231.70 | 10% | Actavis Switzerland AG | | | | FI | PI |
| Adcirca | Tabletten | 20 mg | 56 Tablette(n) | PA | k.A. | Eli Lilly (Suisse) SA | | | | FI | PI |
| Alli | Kautabletten | 27 mg | 42 Tablette(n) | PA | k.A. | GlaxoSmithKline Consumer Healthcare AG | | | | | |
| Alli | Kautabletten | 27 mg | 84 Tablette(n) | PA | k.A. | GlaxoSmithKline Consumer Healthcare AG | | | | | |
| Alli | Kautabletten | 27 mg | 120 Tablette(n) | PA | k.A. | GlaxoSmithKline Consumer Healthcare AG | | | | | |
| Atorvastatin-Mepha 10 mg | Filmtabletten | 10 mg | 30 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Atorvastatin-Mepha 10 mg | Filmtabletten | 10 mg | 100 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Atorvastatin-Mepha 20 mg | Filmtabletten | 20 mg | 30 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Atorvastatin-Mepha 20 mg | Filmtabletten | 20 mg | 100 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Atorvastatin-Mepha 40 mg | Filmtabletten | 40 mg | 30 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Atorvastatin-Mepha 40 mg | Filmtabletten | 40 mg | 100 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Atorvastatin-Mepha 80 mg | Filmtabletten | 80 mg | 30 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Atorvastatin-Mepha 80 mg | Filmtabletten | 80 mg | 100 Tablette(n) | PA | k.A. | Mepha Pharma AG | | | | | |
| Avonex Pen | Injektionslösung in einem Fertigpen | 30 | 4 Set(s) | 1623.65 | 10% | Biogen Idec Switzerland AG | | | | | |
| Clopidolut 75 mg | Filmtabletten | 75 mg | 28 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Clopidolut 75 mg | Filmtabletten | 75 mg | 50 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Clopidolut 75 mg | Filmtabletten | 75 mg | 84 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Daxas 500 ug | Filmtabletten | 0.5 mg | 30 Tablette(n) | 78.55 | 10% | Nycomed Pharma AG | | | | FI | PI |
| Daxas 500 ug | Filmtabletten | 0.5 mg | 90 Tablette(n) | PA | k.A. | Nycomed Pharma AG | | | | FI | PI |
| Donepezil Orion 10 mg | Tabletten | 10 mg | 28 Tablette(n) | PA | k.A. | Orion Pharma AG | | | | | |
| Donepezil Orion 10 mg | Tabletten | 10 mg | 56 Tablette(n) | PA | k.A. | Orion Pharma AG | | | | | |
| Donepezil Orion 10 mg | Tabletten | 10 mg | 98 Tablette(n) | PA | k.A. | Orion Pharma AG | | | | | |
| Donepezil Orion 5 mg | Tabletten | 5 mg | 28 Tablette(n) | PA | k.A. | Orion Pharma AG | | | | | |
| Donepezil Orion 5 mg | Tabletten | 5 mg | 56 Tablette(n) | PA | k.A. | Orion Pharma AG | | | | | |
| Donepezil Orion 5 mg | Tabletten | 5 mg | 98 Tablette(n) | PA | k.A. | Orion Pharma AG | | | | | |
| Flumazenil B. Braun | Injektionslösung | 0.5mg / 5ml | 5 Ampulle(n) | PA | k.A. | B. Braun Medical AG | | | | | |
Imipenem-Cilastatin Fresenius 500 mg/500 mg | Lyophilisat | 1000 mg | 10 1 Durchstechflasche(n) à 20 ml | PA | k.A. | Fresenius Kabi (Schweiz) AG | | | | | |
Imipenem-Cilastatin Fresenius 500 mg/500 mg | Lyophilisat | 1000 mg | 10 x 100 ml | PA | k.A. | Fresenius Kabi (Schweiz) AG | | | | | |
| Levetiracetam APL 1000 mg | Filmtabletten | 1000 mg | 30 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Levetiracetam APL 1000 mg | Filmtabletten | 1000 mg | 100 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Levetiracetam APL 1000 mg | Filmtabletten | 1000 mg | 200 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Levetiracetam APL 250 mg | Filmtabletten | 250 mg | 30 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Levetiracetam APL 500 mg | Filmtabletten | 500 mg | 20 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Levetiracetam APL 500 mg | Filmtabletten | 500 mg | 100 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Levetiracetam APL 500 mg | Filmtabletten | 500 mg | 200 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Levomin | Filmtabletten | 0.18 mg | 21 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Levomin | Filmtabletten | 0.18 mg | 3 x 21 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Menveo | Lyophilisat und Lösung (Durchstechflaschen) | 15 µg/ml | Durchstechflasche(n) | PA | k.A. | Novartis Pharma Schweiz AG | | I/B | | | |
| Menveo | Lyophilisat und Lösung (Durchstechflaschen) | 15 µg/ml | 5 Durchstechflasche(n) | PA | k.A. | Novartis Pharma Schweiz AG | | I/B | | | |
| Olanzact 10 mg | Filmtabletten | 10 mg | 28 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 10 mg | Filmtabletten | 10 mg | 56 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 15 mg | Filmtabletten | 15 mg | 28 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 15 mg | Filmtabletten | 15 mg | 56 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 2,5 mg | Filmtabletten | 2.5 mg | 28 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 2,5 mg | Filmtabletten | 2.5 mg | 56 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 20 mg | Filmtabletten | 20 mg | 28 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 20 mg | Filmtabletten | 20 mg | 56 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 5 mg | Filmtabletten | 5 mg | 28 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 5 mg | Filmtabletten | 5 mg | 56 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 7,5 mg | Filmtabletten | 7.5 mg | 28 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Olanzact 7,5 mg | Filmtabletten | 7.5 mg | 56 Tablette(n) | PA | k.A. | Actavis Switzerland AG | | | | | |
| Ovitrelle PEN 250 ug | Injektionslösung in einer Patrone | 250 | Set(s) | PA | k.A. | Merck (Schweiz) AG | | | | | |
Perindopril APL 4 mg comprimés | Tabletten | 4 mg | 30 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
Perindopril APL 4 mg comprimés | Tabletten | 4 mg | 90 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
Perindopril APL 8 mg comprimés | Tabletten | 8 mg | 30 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
Perindopril APL 8 mg comprimés | Tabletten | 8 mg | 90 Tablette(n) | PA | k.A. | Aurobindo Switzerland AG | | | | | |
| Physiogel balanced | Infusionslösung | | 10 x 500 ml | PA | k.A. | B. Braun Medical AG | | | | | |
| Physiogel balanced | Infusionslösung | | 10 x 1000 ml | PA | k.A. | B. Braun Medical AG | | | | | |
| Physiogel balanced | Infusionslösung | | 20 x 500 ml | PA | k.A. | B. Braun Medical AG | | | | | |
| Pramip 0,125 mg | Tabletten | 0.088 mg | 30 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Pramip 0,25 mg | Tabletten | 0.18 mg | 30 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Pramip 0,25 mg | Tabletten | 0.18 mg | 100 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Pramip 0,5 mg | Tabletten | 0.35 mg | 100 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Pramip 1,0 mg | Tabletten | 0.7 mg | 100 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Pramip 1,5 mg | Tabletten | 1.1 mg | 30 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Pramip 1,5 mg | Tabletten | 1.1 mg | 100 Tablette(n) | PA | k.A. | Dermapharm AG | | | | | |
| Quetiapin Streuli 100 mg | Filmtabletten | 100 mg | 60 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 100 mg | Filmtabletten | 100 mg | 100 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 150 mg | Filmtabletten | 150 mg | 60 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 150 mg | Filmtabletten | 150 mg | 100 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 200 mg | Filmtabletten | 200 mg | 60 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 200 mg | Filmtabletten | 200 mg | 100 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 25 mg | Filmtabletten | 25 mg | 60 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 300 mg | Filmtabletten | 300 mg | 60 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Quetiapin Streuli 300 mg | Filmtabletten | 300 mg | 100 Tablette(n) | PA | k.A. | Streuli Pharma AG | | | | | |
| Renvela | | | 60 Sachet(s) | 280.25 | 10% | Genzyme GmbH | L | | | | |
| Renvela | | | 180 Tablette(n) | 280.25 | 10% | Genzyme GmbH | L | | | | |
| Valsartan-Teva 160 mg | Filmtabletten | 160 mg | 28 Tablette(n) | PA | k.A. | Teva Pharma AG | | | | | |
| Valsartan-Teva 160 mg | Filmtabletten | 160 mg | 98 Tablette(n) | PA | k.A. | Teva Pharma AG | | | | | |
| Valsartan-Teva 40 mg | Filmtabletten | 40 mg | 28 Tablette(n) | PA | k.A. | Teva Pharma AG | | | | | |
| Valsartan-Teva 80 mg | Filmtabletten | 80 mg | 28 Tablette(n) | PA | k.A. | Teva Pharma AG | | | | | |
| Valsartan-Teva 80 mg | Filmtabletten | 80 mg | 98 Tablette(n) | PA | k.A. | Teva Pharma AG | | | | | |
Xylometazolin 0.1% Q- Generics | Nasenspray | 0.14 mg | 15 ml | PA | k.A. | Quisisana Pharma AG | | | | | |